131I SPECT/CT provides prognostic information in patients with differentiated thyroid cancer
Patients without LNM on post-therapy <sup>131</sup>I SPECT/CT have better chances for early CR and longer PFS. Patients with LNM benefit from early reoperations but treatment strategies should be tailored based on LNM characteristics.
Authors
- Aleksander Kosmala (ORCID: https://orcid.org/0000-0002-9313-9356)
- Philipp E. Hartrampf (ORCID: https://orcid.org/0000-0001-5622-9849)
- Alexander Kerscher (ORCID: https://orcid.org/0000-0001-7742-570X)
- Andreas K. Buck (ORCID: https://orcid.org/0000-0002-6447-0613)
- Nicolas Schlegel (ORCID: https://orcid.org/0000-0001-5705-3945)
- Marieke Heinrich
- Kerstin Michalski (ORCID: https://orcid.org/0000-0001-8715-7788)
- Frederik A. Verburg (ORCID: https://orcid.org/0000-0002-7161-0979)
- Natalie Hasenauer
- Elias Blickle
Institutions
- Comprehensive Cancer Center Mainfranken (DE)
- Universitätsklinikum Würzburg (DE)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2025-03-15
- DOI
- https://doi.org/10.1007/s00259-025-07187-1
- Citations
- 2
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.59
Funders
- Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg